ReShape Lifesciences Inc.
RSLS
$0.365
-$0.015-3.95%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -1.76M | -1.58M | -1.60M | -2.19M | -1.70M |
| Total Depreciation and Amortization | 5.00K | 5.00K | 6.00K | 6.00K | 7.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 396.00K | 262.00K | -26.00K | -339.00K | -5.00K |
| Change in Net Operating Assets | 673.00K | 1.00M | 258.00K | 454.00K | -761.00K |
| Cash from Operations | -687.00K | -311.00K | -1.36M | -2.07M | -2.46M |
| Capital Expenditure | -- | -- | -- | -- | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | 0.00 |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | 0.00 |
| Total Debt Issued | 653.00K | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00 | 0.00 | 24.00K | -- | 5.12M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 338.00K |
| Cash from Financing | 653.00K | 0.00 | 24.00K | -- | 5.46M |
| Foreign Exchange rate Adjustments | -16.00K | 1.00K | 7.00K | -8.00K | 6.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -50.00K | -310.00K | -1.33M | -2.08M | 3.01M |